In the BioHarmony Drug Report Database

"Preview" Icon

Ciclesonide

Alvesco, Omnaris, Zetonna (ciclesonide) is a small molecule pharmaceutical. Ciclesonide was first approved as Alvesco on 2006-10-20. It is used to treat allergic rhinitis perennial and allergic rhinitis seasonal in the USA. The pharmaceutical is active against glucocorticoid receptor. Alvesco’s patent is valid until 2028-02-01 (FDA).

 

Trade Name

 

Alvesco, Omnaris, Zetonna
 

Common Name

 

ciclesonide
 

ChEMBL ID

 

CHEMBL2040682
 

Indication

 

allergic rhinitis perennial, allergic rhinitis seasonal
 

Drug Class

 

Topical steroids (acetal derivatives)

Image (chem structure or protein)

Ciclesonide structure rendering